Emerging companies find it increasingly difficult to reach the right person when seeking funding and/or partners. Through the “Meet with…” Series, we provide emerging companies with greater access to partnering and/or financing opportunities.

In this session, Licensing Directors from Bayer will talk to potential licensees to first explain what they are looking for in a company. After the presentation, attendees will have lunch with the Bayer team.

Bayer's areas of Interest:

Oncology
focusing on anti-angiogenic, anti-tumor and selective anti-proliferative therapies for solid tumors.

Cardiology
focusing on novel approaches to the care of chronic and/or acute pulmonary hypertension, atrial fibrillation, heart failure, acute coronary syndrome, ischemic stroke, peripheral arterial occlusive disease, disseminated intravascular coagulation, acute lung injury/adult respiratory distress syndrome, and cardioprotection.

Gynecology
focusing on novel treatment options for endometriosis (adenomyosis uteri/endometriosis interna) and uterine fibroids (uterine leiomyoma) and abnormal uterine bleeding (heavy menstrual bleeding, breakthrough bleeding).

In vivo Imaging
focusing on oncology (early diagnosis and staging, early therapy response, predictive stratification of patients) and CNS (Alzheimer's disease, other forms of dementia, neuroinflammation), using positron emission tomography (PET) as modality.

Technologies Bayer is interested in:

• Target validation technologies (RNA knockdown, ko mice)
• Fragment based Screening technologies for lead identification
• Affinity based Screening technologies for lead identification
• diverse antibody libraries
• antibody discovery technologies
• protein expression technologies

Click here to view Bayer's areas of interest»

Venue
San Jose BioCenter
5941 Optical Court
Second Floor
San Jose, CA 95138
Click here for Venue Directions»